Continental Advisors LLC Gilead Sciences, Inc. Call Options Transaction History

Continental Advisors LLC

$207 Million
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $1.72 Million - $2.17 Million	-25,800 Reduced 50.79%	25,000 $2.1 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $1.82 Million - $2.1 Million	28,800 Added 130.91%	50,800 $3.49 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $1.57 Million - $1.92 Million	22,000 New	22,000 $1.61 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $934,800 - $1.34 Million	-15,000 Reduced 33.33%	30,000 $2.58 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $595,400 - $680,100	-10,000 Reduced 18.18%	45,000 $2.78 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.44 Million - $1.63 Million	-25,000 Reduced 31.25%	55,000 $3.4 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.74 Million - $2.18 Million	30,000 Added 60.0%	80,000 $4.76 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $2.71 Million - $2.92 Million	40,000 Added 400.0%	50,000 $3.49 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.8 Million - $2.05 Million	-30,000 Reduced 75.0%	10,000 $646,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $793,100 - $903,700	14,000 Added 53.85%	40,000 $2.33 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $993,600 - $1.25 Million	16,000 Added 160.0%	26,000 $1.64 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $723,400 - $840,000	-10,000 Reduced 50.0%	10,000 $769,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $926,640 - $1.03 Million	-13,000 Reduced 39.39%	20,000 $1.54 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $1.3 Million - $1.51 Million	20,000 Added 153.85%	33,000 $2.34 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.24 Million - $1.51 Million	-17,000 Reduced 56.67%	13,000 $980,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $1.39 Million - $1.64 Million	-19,600 Reduced 39.52%	30,000 $2.15 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.58 Million - $4.24 Million	49,600	49,600 $4.02 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.5 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.99 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.65 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.5 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Continental Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Continental Advisors LLC with notifications on news.

Account